Joaquin, Mailyn C.
HRN: 24-46-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/30/2024
02/06/2024
IV
1.5gm
Q6
Infected Breast Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes